Vivimed has offices in Hyderabad, India, with five different functional manufacturing centres in proximity to the central office hub. Vivimed has a new state-of-the-art R&D facility close to the central office, and parallel R&D facilities in the UK, which also incorporates the European office for finance, marketing and administration, within this UK facility is the Company's dedicated REACH compliance unit, a sales and distribution hub in north-eastern USA and a representatives office in Guangzhou, China completes the division profile.
Vivimed Manufacturing Units
Bidar - Anti-microbials, preservatives and sunscreen actives
Bonthapally - Home and Personal Care actives production
Jeedimetla - Capsule, tablet, liquid oral and ointment formulations
Haridwar - small volume parenterals sterile products (eye, ear and nasal drop formulations)
Kashipur - Capsule, tablet, liquid oral and ointment formulations
Alathur - USA FDA approved SOD facility
Klar Sehen - Opthalmic & Pharma Products
In August 2013, as part of its global business strategy to complete its presence across the entire health care value chain, Vivimed completed the acquisition of a US FDA approved 1.2 billion SOD per annum manufacturing facility at Alathur near Chennai, Tamilnadu. This facility earlier belonged to the US pharma MNC Actavis (Watson) and has received US FDA approval 4 times in April 2007, April 2009, Oct 2011 and most recently in Sep 2013. The plant manufacturing capacity can be expanded to 5 billion SOD per annum. This eliminates 3 to 4 years of lead time to build a green field project of this quality and getting the regulatory approvals.
This strategic acquisition gives Vivimed immediate access to regulated markets such as US and European union. US is the largest generic market in the world. This also enables Vivimed to complete the health vare value chain by providing forward integration synergies for Vivimed’s existing API business.
With the acquisition of the Alathur facility and Finoso, Vivimed will now develop its own formulation dossiers, DMFs and ANDAs and start building a filing pipeline with the Alathur facility as the manufacturing site.
The newest member of the Vivimed group, Uquifa is a well-established manufacturer of pharma API’s and intermediates with global coverage operating cGMP sites out of Spain and Mexico. Uquifa sells to more than 70 countries worldwide and has more than 150 active DMF´s filed and 20 COS approved. Uquifa counts amongst its customers the major Generic and Ethical companies operating in the Industry and continues to invest in personnel and facilities to maintain a arrow technology offering to both the Generic Industry and the Ethical Pharmaceutical Industry.
Finoso is a full-service pharmaceutical development services company, focusing its efforts on reducing the cost of product development for the end customer. Founded and managed by an experienced team of professionals who have an excellent track record in product development services, the Finoso team delivers from concept design to ultimate product approval even for the most difficult pharmaceutical dosage forms.
Finoso focuses on product development efforts for multiple markets and develops globally accepted dossiers for simple as well as complex dosage forms. Finoso has state-of-the-art equipment and technologies to develop quality and robust products and has tie-ups with API and finished dosage form (FDF) manufacturing companies in several countries to ensure steady supply of materials and services. Finoso has customers in US, Canada, India, Australia and the European union.
Finoso is focusing on the following business areas:
- Reduce supply chain inefficiencies
- Minimize cost of product development
- Reduce global regulatory imbalances
- Complement pharmaceutical companies' product development efforts
Finoso's scope of business includes:
- Product development -- Generics
- Exclusive formulation projects – Projects from existing generic drugs
- Product development – Drugs going off-patent through 2015 and beyond
- Product development -- Innovators
- Formulation development for innovator molecules
- Formulation support for pre-clinical and clinical testing
Starting in the 90s, the Pharma Division of Vivimed is today seen as a preferred partner by large global players in the areas of collaborative research, joint exploration of new markets and as an efficient supply chain partner who can leverage globally benchmarked plants.
The Specialty Pharma division of Vivimed is a merged entity of VVS Pharma and Creative Healthcare. The Specialty Pharma Division has its inherent strengths in drug delivery ad drug discovery. The division is focused on providing cures in oncology space, arthritis, syndrome X, macular degeneration, psoriasis and stress.
Klar Sehen, the niche ophthalmic formulations Company in India has now tied up with globally renowned Vivimed, a key player in Speciality Chemicals, Hair Dyes, and Pharmaceuticals with global presence. Started in the 90's, the Pharma Division of Vivimed is seen today as the preferred partner by large players in collaborative research. Vivimed provides high performance products of quality and value to improve the lives of its customers.
Now Klar Sehen has started its journey beyond India to reach a global market, starting with the US OTC (OPHTHALMOLOGY PRODUCTS) market, and has launched 4 products which are now stocked in the top 3 retail chains in USA.
Klar Sehen has an enviable track record of providing eye care products for over 3 decades. Our strict adherence to quality and service has helped in winning the trust of millions of satisfied consumers.
The company is dedicated towards providing eye care products in all the relevant segments - Tears Substitutes, Antibiotics, Antiviral, Mydriatics, NSAIDS, Anti allergens, Operative and so on. Klar Sehen's products like RENICOL, DEXACORT-N, IRIGAN, etc. are trusted by Ophthalmologists across India.
Vivimed Labs is certified
ISO9001:2008, ISO14001:2004, OHAS 18001:2007 & SA 8000:2008 via TUV Nord.
These certifications cover quality, environment, occupational health & safety and social accountability management systems for the scope:
Manufacture and supply of speciality chemicals and active pharmaceutical ingredients.
Memberships & Associations
British Association for Chemical Specialities
The British Association for Chemical Specialities (BACS) is a UK-based trade association which represents domestic and international companies operating in the speciality chemicals sector of the chemicals supply chain.
Cosmetic, Toiletry and Perfumery Association
The CTPA is the authoritative public voice representing UK cosmetic and personal care companies involved in sourcing of ingredients, manufacturing, packaging, labelling and distribution, providing members with comprehensive scientific and technical advice.
American Cleaning Institute
The American Cleaning Institute is a trade organisation representing North American manufacturers of household, institutional and industrial cleaning chemicals, cleaning products, their ingredients and finished packaging; oleochemical producers; and chemical distributors to the cleaning product industry.
REACHReady - subsidiary of the Chemical Industries Association
REACHReady is a wholly-owned subsidiary of the Chemical Industries Association, providing comprehensive expert advice on regulations, legislation and documentation for classification, labelling and packaging of products for the European chemicals industry.
Organic Electronics Association
The OE-A is the leading international industry association for organic and printed electronics and represents the entire value chain of this emerging industry. Our members are world-class global companies and institutions, ranging from R&D institutes, component and material suppliers to producers and end-users. More than 200 companies from Europe, North America, Asia and Australia are working together to promote the establishment of a competitive production infrastructure for organic and printed electronics